Russia’s Gamaleya Research Centre Given Green Light for Post-Registration Trials of COVID-19 Vaccine

Russia officially registered its coronavirus vaccine on 11 August. Called Sputnik V, it has become the world’s first vaccine against the COVID-19 infection.

The Russian Gamaleya research centre has received permission to conduct post-registration clinical trials of the coronavirus vaccine, the health ministry said. 

The trials will be carried out in several state-run medical institutions in Moscow.

40,000 volunteers aged 18 years and over will take part in the trials. The participation of each volunteer will last for six months from the day he or she receives the vaccine. 

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button